Perspectives on how novel lipid-lowering therapies may help address current unmet needs
touchMDT for touchCARDIO
Listen to key experts from a multidisciplinary team consider the unmet needs in patients at high risk of ASCVD and how novel lipid-lowering therapies may help
The multidisciplinary team
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This medical education is provided by touchIME.
For further information visit our website: https://touchcardioime.org/novel-lipid-lowering-therapies-for-reducing-ascvd-risk//
Create your
podcast in
minutes
It is Free